Telemetry Investments’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $332K | Sell |
390,000
-132,009
| -25% | -$112K | 0.52% | 47 |
|
|
2022
Q3 | $427K | Buy |
522,009
+61,906
| +13% | +$50.6K | 0.55% | 52 |
|
|
2022
Q2 | $456K | Buy |
460,103
+172,603
| +60% | +$171K | 0.54% | 56 |
|
|
2022
Q1 | $472K | Buy |
287,500
+94,591
| +49% | +$155K | 0.74% | 50 |
|
|
2021
Q4 | $465K | Sell |
192,909
-3,259
| -2% | -$7.86K | 0.6% | 55 |
|
|
2021
Q3 | $949K | Sell |
196,168
-67,807
| -26% | -$328K | 1.28% | 21 |
|
|
2021
Q2 | $705K | Buy |
263,975
+14,969
| +6% | +$40K | 0.97% | 35 |
|
|
2021
Q1 | $767K | Buy |
249,006
+59,925
| +32% | +$185K | 0.87% | 42 |
|
|
2020
Q4 | $673K | Buy |
+189,081
| New | +$673K | 1.14% | 31 |
|
|
2019
Q3 | – | Sell |
-101,218
| Closed | -$379K | – | 55 |
|
|
2019
Q2 | $379K | Sell |
101,218
-48,981
| -33% | -$183K | 0.29% | 40 |
|
|
2019
Q1 | $604K | Buy |
150,199
+15,076
| +11% | +$60.6K | 0.31% | 28 |
|
|
2018
Q4 | $496K | Buy |
+135,123
| New | +$496K | 0.32% | 47 |
|
|
2017
Q4 | – | Sell |
-27,000
| Closed | -$430K | – | 94 |
|
|
2017
Q3 | $430K | Buy |
+27,000
| New | +$430K | 0.15% | 53 |
|